Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine

A Conference Season’s Greeting

It is the holiday season! But many in the industry will be preoccupied with full schedules rather than full stockings, with an abundance of conferences in the weeks leading up to year-end. Over the last few months, I’ve attended various cell and gene therapy talks and roundtable discussions to glean an overview of the current state of the field. 

At the Cell and Gene Therapy Manufacturing conference in Twickenham, UK, there were several interesting case studies demonstrating how processes can be effectively scaled out – from late-stage solid tumor clinical trials to lentiviral vectors. Pernille Linnert Jensen from Novo Nordisk also offered an example of how to transition from large molecule (antibodies in this case) to stem cell manufacturing. For Pernille, training and education was crucial to the endeavor. 

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register